From October 11-14, Advaxia’s Quali ed Person, Dr. Stefania Di Marco, attended the World Vaccine Congress Europe 2022 in Barcelona, Spain. She was joined by Patrick DePalma, Advaxia’s Global VP of Business Development and Marketing.
Dr. Di Marco presented on 14Oct @ 11:15 on the topic of Viral Vector Vaccine Manufacture:
Viral Vector Vaccines: Adeno Virus Productions
Fully integrated service portfolio for adenovirus vaccines — from development, to manufacturing of pre-clinical and clinical supply.
- Merits and potential pitfalls of using the adenovirus in comparison to other systems
- Applications of adenoviral-mediated vaccines with an emphasis on the SARS-CoV-2 vaccine AZD1222
Meet the Advaxia team at the upcoming World Vaccine Congress Washington 2023 or World Vaccine Congress Europe 2023.